At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,352 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Multicenter Clinical Research for Diagnosis of Epithelial Ovarian Cancer Using OCS Test
In Brief
An observational study for Epithelial Ovarian Cancer and Adnexal Mass. Completed, enrolled 1,352 participants across 1 site.
Detailed Summary
The study is designed to confirm the performance of the 3D Medicines Corporation OCS test in diagnosis of epithelial ovarian cancer in patients with adnexal mass. To this end, blood samples from female patients with adnexal mass required surgical resection from four centers are obtained and analysis in the study.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsEpithelial Ovarian Cancer, Adnexal Mass
CountriesChina
Timeline
N/ACompletedFinished
2020202120222023202420252026
Enrollment StartOct 2019
Primary CompletionApr 2023
Study CompletionMay 2023
First PostedApr 2024
TodayJul 2026
First PostedApr 16, 2024
Enrollment StartOct 9, 2019
Primary CompletionApr 18, 2023
Study CompletionMay 5, 2023
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 2.2 years ago